Symbols / MDRX $4.74 +3.04% Veradigm Inc.

Healthcare • Health Information Services • United States • PNK
MDRX Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO —
Exch · Country PNK · United States
Market Cap 516.62M
Enterprise Value 282.06M
Income -291.54M
Sales 594.41M
FCF (ttm) -7.99M
Book/sh 7.43
Cash/sh 4.52
Employees —
Insider 10d —
IPO Jul 26, 1999
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 15.54
PEG 1.95
P/S 0.87
P/B 0.64
P/C —
EV/EBITDA -6.94
EV/Sales 0.47
Quick Ratio 1.17
Current Ratio 1.29
Debt/Eq 18.59
LT Debt/Eq —
EPS (ttm) -2.70
EPS next Y 0.30
EPS Growth -1.80%
Revenue Growth 5.00%
EPS Gr Q/Q -10.20%
Rev Gr Q/Q —
Earnings (next) 2026-05-26
Earnings (prior) 2026-05-26
ROA -3.69%
ROE -31.05%
ROIC —
Gross Margin 50.85%
Oper. Margin 16.59%
Profit Margin -49.05%
Shs Outstand 108.99M
Shs Float 81.97M
Insider Own 3.87%
Instit Own 66.25%
Short Float —
Short Ratio 3.92
Short Interest 8.13M
52W High 6.00
vs 52W High -21.00%
52W Low 3.00
vs 52W Low 58.00%
Beta —
Impl. Vol. —
Rel Volume 0.09
Avg Volume 110.92K
Volume 9.96K
Target (mean) $6.00
Tgt Median $5.00
Tgt Low $5.00
Tgt High $8.00
# Analysts 3
Recom Buy
Prev Close $4.60
Price $4.74
Change 3.04%
About

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; clinical data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. Additionally, the company serves physician practices, hospitals, laboratory and radiology centers, urgent care facilities, health IT companies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.00
Mean price target
2. Current target
$4.74
Latest analyst target
3. DCF / Fair value
$-1.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.74
Low
$5.00
High
$8.00
Mean
$6.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-01-31 main Stephens & Co. Equal-Weight → Equal-Weight $13
2024-05-28 main TD Cowen Buy → Buy $15
2024-03-19 down Deutsche Bank Buy → Hold $10
2024-01-19 main RBC Capital Outperform → Outperform $11
2024-01-03 init Barclays — → Equal-Weight $11
2023-11-14 reit Stephens & Co. Equal-Weight → Equal-Weight $13
2023-10-10 reit Stephens & Co. Equal-Weight → Equal-Weight $13
2023-07-06 down Argus Research Buy → Hold —
2023-04-12 init Stephens & Co. — → Equal-Weight $13
2023-02-01 down Piper Sandler Overweight → Neutral $19
2022-12-07 up Argus Research Hold → Buy $26
2022-11-18 main JP Morgan — → Underweight $20
2022-11-09 up Goldman Sachs Neutral → Buy $23
2022-09-16 init Keybanc — → Sector Weight —
2022-07-12 init Goldman Sachs — → Neutral $21
2022-06-10 main Piper Sandler — → Neutral $17
2022-05-06 main Piper Sandler — → Neutral $19
2022-03-18 main Piper Sandler — → Neutral $22
2022-03-04 up Deutsche Bank Hold → Buy $26
2022-03-03 main SVB Leerink — → Outperform $24
News
RSS: Latest MDRX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-01 JACOBSON ERIC L General Counsel — 75,000 — —
2026-04-01 TRIGG DONALD Chief Executive Officer — 552,465 — —
2026-04-01 SYED TEHSIN M Officer — 220,986 — —
2026-04-01 BAKER TALLY Officer — 110,493 — —
2025-11-03 SYED TEHSIN M Chief Technology Officer — 423,998 — —
2025-11-03 BAKER TALLY Officer — 105,999 — —
2025-09-02 TRIGG DONALD Chief Executive Officer — 571,428 $5.25 $2,999,997
2025-06-02 FELT BRUCE C. JR. Director — 46,512 $4.30 $200,002
2025-06-02 RODRIGUEZ SUSAN Director — 46,512 $4.30 $200,002
2025-06-02 VAKHARIA TEJAL General Counsel — 69,768 $4.30 $300,002
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2021-12-31
Total Revenue
577.43
Operating Revenue
577.43
Cost Of Revenue
294.98
Reconciled Cost Of Revenue
231.49
Gross Profit
282.45
Operating Expense
205.15
Research And Development
84.10
Selling General And Administration
111.76
Total Expenses
500.13
Operating Income
77.30
Total Operating Income As Reported
76.77
EBITDA
243.41
Normalized EBITDA
163.62
Reconciled Depreciation
72.78
EBIT
170.63
Total Unusual Items
79.79
Total Unusual Items Excluding Goodwill
79.79
Special Income Charges
4.33
Impairment Of Capital Assets
0.00
Write Off
5.69
Net Income
139.56
Pretax Income
157.71
Net Non Operating Interest Income Expense
-12.71
Interest Expense Non Operating
12.93
Net Interest Income
-12.71
Interest Expense
12.93
Interest Income Non Operating
0.21
Interest Income
0.21
Other Income Expense
93.12
Other Non Operating Income Expenses
11.58
Gain On Sale Of Security
75.46
Gain On Sale Of Business
8.37
Tax Provision
29.93
Tax Rate For Calcs
0.00
Tax Effect Of Unusual Items
15.16
Net Income Including Noncontrolling Interests
139.56
Net Income From Continuing Operation Net Minority Interest
127.78
Net Income From Continuing And Discontinued Operation
139.56
Net Income Continuous Operations
127.78
Net Income Discontinuous Operations
11.79
Minority Interests
0.00
Normalized Income
63.15
Net Income Common Stockholders
139.56
Diluted EPS
1.01
Basic EPS
1.07
Basic Average Shares
130.10
Diluted Average Shares
138.66
Diluted NI Availto Com Stockholders
139.56
Amortization
9.28
Amortization Of Intangibles Income Statement
9.28
Depreciation Amortization Depletion Income Statement
9.28
Depreciation And Amortization In Income Statement
9.28
Earnings From Equity Interest
1.76
Gain On Sale Of PPE
1.65
Line Item Trend 2022-12-31 2021-12-31
Total Assets
1,504.72
-34.89%
2,311.03
Current Assets
679.65
+4.69%
649.21
Cash Cash Equivalents And Short Term Investments
446.59
+234.13%
133.66
Cash And Cash Equivalents
446.59
+234.13%
133.66
Receivables
175.72
-4.95%
184.86
Accounts Receivable
119.15
-0.46%
119.70
Gross Accounts Receivable
141.89
+0.41%
141.32
Allowance For Doubtful Accounts Receivable
-22.74
-5.19%
-21.62
Other Receivables
56.57
-13.19%
65.17
Taxes Receivable
—
0.00
Prepaid Assets
55.82
+9.01%
51.21
Restricted Cash
1.31
-0.08%
1.31
Assets Held For Sale Current
0.00
-100.00%
277.63
Other Current Assets
0.21
-61.90%
0.55
Total Non Current Assets
825.07
-50.35%
1,661.81
Net PPE
21.44
-40.54%
36.06
Gross PPE
176.07
-28.69%
246.93
Accumulated Depreciation
-154.64
+26.67%
-210.87
Properties
0.00
0.00
Machinery Furniture Equipment
149.66
-30.12%
214.17
Other Properties
11.98
-34.63%
18.32
Leases
14.44
+0.00%
14.44
Goodwill And Other Intangible Assets
697.05
-4.41%
729.19
Goodwill
532.64
+6.88%
498.36
Other Intangible Assets
164.41
-28.78%
230.83
Investments And Advances
58.13
+2.53%
56.70
Non Current Accounts Receivable
—
56.80
Non Current Deferred Assets
37.19
0.00
Non Current Deferred Taxes Assets
37.19
0.00
Non Current Prepaid Assets
10.10
-26.94%
13.83
Other Non Current Assets
1.16
-99.86%
826.04
Total Liabilities Net Minority Interest
487.22
-48.75%
950.64
Current Liabilities
230.31
-52.85%
488.42
Payables And Accrued Expenses
97.67
+50.10%
65.07
Payables
34.85
+462.35%
6.20
Accounts Payable
30.84
+1318.63%
2.17
Current Accrued Expenses
62.82
+6.71%
58.87
Pensionand Other Post Retirement Benefit Plans Current
35.94
+18.42%
30.35
Total Tax Payable
4.01
-0.37%
4.02
Current Debt And Capital Lease Obligation
6.61
+7.74%
6.13
Current Capital Lease Obligation
6.61
+7.74%
6.13
Current Deferred Liabilities
90.10
+2.51%
87.89
Current Deferred Revenue
90.10
+2.51%
87.89
Other Current Liabilities
—
298.99
Total Non Current Liabilities Net Minority Interest
256.90
-44.42%
462.22
Liabilities Heldfor Sale Non Current
0.00
-100.00%
42.71
Long Term Debt And Capital Lease Obligation
212.84
-41.98%
366.82
Long Term Debt
200.40
-42.75%
350.06
Long Term Capital Lease Obligation
12.44
-25.75%
16.75
Non Current Deferred Liabilities
0.00
-100.00%
18.87
Non Current Deferred Revenue
0.00
-100.00%
0.19
Non Current Deferred Taxes Liabilities
0.00
-100.00%
18.69
Other Non Current Liabilities
44.07
+30.29%
33.82
Stockholders Equity
1,017.50
-25.20%
1,360.38
Common Stock Equity
1,017.50
-25.20%
1,360.38
Capital Stock
2.79
+1.01%
2.77
Common Stock
2.79
+1.01%
2.77
Preferred Stock
—
0.00
Share Issued
279.55
+1.03%
276.70
Ordinary Shares Number
106.07
-8.65%
116.11
Treasury Shares Number
173.48
+8.03%
160.59
Additional Paid In Capital
1,925.20
-1.89%
1,962.39
Retained Earnings
645.81
-10.28%
719.79
Gains Losses Not Affecting Retained Earnings
-0.07
+97.32%
-2.76
Treasury Stock
1,556.23
+17.74%
1,321.81
Total Equity Gross Minority Interest
1,017.50
-25.20%
1,360.38
Total Capitalization
1,217.90
-28.80%
1,710.44
Working Capital
449.33
+179.46%
160.79
Invested Capital
1,217.90
-28.80%
1,710.44
Total Debt
219.44
-41.16%
372.95
Net Debt
—
216.40
Capital Lease Obligations
19.05
-16.77%
22.89
Net Tangible Assets
320.46
-49.23%
631.19
Tangible Book Value
320.46
-49.23%
631.19
Available For Sale Securities
58.13
+2.53%
56.70
Investmentin Financial Assets
58.13
+2.53%
56.70
Line Item Trend 2022-12-31 2021-12-31
Operating Cash Flow
115.56
+250.83%
-76.62
Cash Flow From Continuing Operating Activities
138.82
+22.10%
113.70
Cash From Discontinued Operating Activities
-23.26
+87.78%
-190.31
Net Income From Continuing Operations
-86.46
-161.95%
139.56
Depreciation Amortization Depletion
115.92
+59.29%
72.78
Depreciation And Amortization
115.92
+59.29%
72.78
Other Non Cash Items
100.28
+213.65%
-88.24
Stock Based Compensation
25.12
+112.71%
11.81
Asset Impairment Charge
15.12
+165.94%
5.69
Deferred Tax
-55.88
-11230.88%
0.50
Deferred Income Tax
-55.88
-11230.88%
0.50
Operating Gains Losses
1.14
+111.29%
-10.13
Change In Working Capital
23.57
+228.97%
-18.28
Change In Receivables
9.55
+3815.56%
-0.26
Change In Prepaid Assets
-0.78
-102.41%
32.20
Change In Payables And Accrued Expense
1.36
+108.90%
-15.31
Change In Accrued Expense
-26.51
-405.86%
-5.24
Change In Payable
27.87
+376.68%
-10.07
Change In Account Payable
27.87
+376.68%
-10.07
Change In Other Working Capital
7.68
+120.21%
-37.98
Change In Other Current Assets
-4.49
-357.69%
1.74
Change In Other Current Liabilities
10.25
+670.96%
1.33
Investing Cash Flow
585.15
+4708.90%
-12.70
Cash Flow From Continuing Investing Activities
598.28
+2293.14%
25.00
Cash From Discontinued Investing Activities
-13.14
+65.15%
-37.70
Capital Expenditure
-32.27
+22.03%
-41.38
Capital Expenditure Reported
-32.27
+22.03%
-41.38
Net Investment Purchase And Sale
-9.93
-310.29%
-2.42
Purchase Of Investment
-9.93
-310.29%
-2.42
Net Business Purchase And Sale
640.48
+830.85%
68.81
Purchase Of Business
-31.99
0.00
Gain Loss On Sale Of Business
0.00
+100.00%
-8.37
Financing Cash Flow
-444.91
-71.87%
-258.87
Cash Flow From Continuing Financing Activities
-444.91
-71.87%
-258.87
Net Issuance Payments Of Debt
-178.36
-201.92%
175.00
Issuance Of Debt
21.64
-91.34%
250.00
Repayment Of Debt
-200.00
-166.67%
-75.00
Long Term Debt Issuance
21.64
-91.34%
250.00
Long Term Debt Payments
-200.00
-166.67%
-75.00
Net Long Term Debt Issuance
-178.36
-201.92%
175.00
Short Term Debt Issuance
—
250.00
Short Term Debt Payments
—
-75.00
Net Short Term Debt Issuance
—
-75.00
Net Common Stock Issuance
-234.43
+43.84%
-417.44
Common Stock Payments
-234.43
+43.84%
-417.44
Repurchase Of Capital Stock
-234.43
+43.84%
-417.44
Net Other Financing Charges
-32.13
-95.63%
-16.42
Changes In Cash
255.80
+173.47%
-348.18
Effect Of Exchange Rate Changes
0.45
+1514.29%
0.03
Beginning Cash Position
191.65
-64.50%
539.80
End Cash Position
447.90
+133.71%
191.65
Free Cash Flow
83.30
+170.59%
-118.00
Earnings Losses From Equity Investments
1.14
+165.05%
-1.76
Sale Of Business
672.47
+877.34%
68.81
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category